Bauro, Myrel B.

HRN: 25-27-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2024
CIPROFLOXACIN 500MG (TAB)
06/19/2024
06/26/2024
PO
500mg
Q12
Complicated UTI
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: